We are glad to announce that the research activities regarding the production and the separation of Ag-111 have been acknowledged with two new papers. The first one, entitled “Production and characterization of Ag-111 radioisotope for medical use in a TRIGA Mark II nuclear research reactor”, was published by Applied Radiation and Isotopes, while the second…
Read more
We are happy to announce the publication of two new papers regarding the work of our laser group. The first one, entitled “Laser photo-ionization study of natAg using opto-galvanic signal at SPES offline laser lab”, was published by the Journal of Instrumentation, while the second one, “Resonant laser lonization and fine-structure study of silver in…
Read more
The SPES-ISOLPHARM laser group took part to the 6th International Conference Frontiers in Diagnostic Technologies (ICFDT6), organized by ENEA and INFN in Frascati (Italy) from 19th to 21st October 2022. ICFDT6 was an interdisciplinary conference, hosting scientists and engineers involved in high energy and accelerator physics and technology, nuclear fusion plasmas, space and astrophysics research,…
Read more
111-Ag was produced by neutron capture in a natPd target at the LENA Laboratory TRIGA Mark II nuclear reactor (Pavia University). The spectrum was obtained by irradiating 70 mg of natural Pd for one hour in the TRIGA Central Thimble.
